Holen Sie sich die Stockscreener-App
19.75
0.53%
-0.115
Schlusskurs vom Vortag:
$19.86
Offen:
$19.8
24-Stunden-Volumen:
668.80K
Relative Volume:
0.25
Marktkapitalisierung:
$4.98B
Einnahmen:
$773.78M
Nettoeinkommen (Verlust:
$155.51M
KGV:
30.86
EPS:
0.6399
Netto-Cashflow:
$355.38M
1W Leistung:
+1.62%
1M Leistung:
-3.26%
6M Leistung:
+10.36%
1J Leistung:
+14.32%
1-Tages-Spanne:
$19.70
$19.92
1-Wochen-Bereich:
$19.09
$19.92
52-Wochen-Spanne:
$15.75
$21.07
Sabra Healthcare Reit Inc Stock (SBRA) Company Profile
Firmenname
Sabra Healthcare Reit Inc
Sektor
Telefon
888-393-8248
Adresse
1781 FLIGHT WAY, TUSTIN, CA
Compare SBRA vs WELL, VTR, OHI, DOC, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SBRA
Sabra Healthcare Reit Inc
|
19.75 | 5.01B | 773.78M | 155.51M | 355.38M | 0.6399 |
WELL
Welltower Inc
|
201.02 | 141.18B | 10.83B | 961.84M | 2.11B | -0.7091 |
VTR
Ventas Inc
|
83.06 | 39.55B | 5.83B | 261.52M | 1.32B | 0.5422 |
OHI
Omega Healthcare Investors Inc
|
44.92 | 13.30B | 1.20B | 609.47M | 810.60M | 1.9317 |
DOC
Healthpeak Properties Inc
|
16.71 | 11.49B | 2.82B | 100.19M | 1.15B | 0.1011 |
AHR
American Healthcare Reit Inc
|
47.13 | 9.04B | 2.27B | 70.82M | 165.88M | 0.4079 |
Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | UBS | Neutral |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-01-17 | Herabstufung | Truist | Buy → Hold |
| 2025-01-07 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-12-05 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-09-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-10-03 | Eingeleitet | Wedbush | Outperform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-27 | Eingeleitet | Berenberg | Hold |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-11-14 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2022-04-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-03-11 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-02-18 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-09-30 | Hochstufung | Truist | Hold → Buy |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-05-21 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-10 | Hochstufung | Stifel | Hold → Buy |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-13 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-01-08 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2020-12-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-06-23 | Hochstufung | Scotiabank | Sector Underperform → Sector Perform |
| 2020-06-08 | Fortgesetzt | JMP Securities | Mkt Perform |
| 2020-05-18 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-02-26 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-02-05 | Eingeleitet | Berenberg | Hold |
| 2019-12-20 | Eingeleitet | Mizuho | Neutral |
| 2019-12-18 | Hochstufung | Citigroup | Sell → Neutral |
| 2019-10-14 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-09-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2018-12-18 | Herabstufung | SunTrust | Buy → Hold |
| 2018-11-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-05-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-03-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-02-22 | Bestätigt | Stifel | Hold |
| 2017-12-21 | Herabstufung | Jefferies | Buy → Hold |
| 2017-09-25 | Eingeleitet | CapitalOne | Equal Weight |
Alle ansehen
Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten
CareTrust REIT, Inc. (CTRE) stock price, news, quote and history - Yahoo Finance UK
10 best REITs to invest in - InvestmentNews
Sabra Health Care REIT, Inc. (SBRA) Stock forecasts - Yahoo Finance UK
CareTrust REIT, Inc. (CTRE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vanguard disaggregates holdings; reports 0% in Sabra Health Care REIT (SBRA) - Stock Titan
Sabra Health Care REIT EVP Flores sells $302k in shares - Investing.com Australia
Sabra Health Care (SBRA) EVP sells 15,231 shares at $19.86 - Stock Titan
Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $22.00 at Wells Fargo & Company - MarketBeat
Nordea Investment Management AB Lowers Stake in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Tudor Investment Corp ET AL Takes $7.58 Million Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
97,730 Shares in Sabra Healthcare REIT, Inc. $SBRA Acquired by Pensionfund PDN - MarketBeat
Sabra Health Care REIT, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
JPMorgan Chase & Co. Has $66.90 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Health Care REIT, Inc. to Attend the 2026 NIC Spring Conference - Business Wire
Is Sabra Health Care REIT (SBRA) Still Attractive After Strong Multi‑Year Share Price Gains - simplywall.st
Engineers Gate Trims Sabra Health Care REIT Stake as Investors Track Rental Income Trends - The Motley Fool
Engineers Gate Sells $28M in Sabra Health Care REIT SharesNews and Statistics - IndexBox
Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Engineers Gate Trims Sabra Health Care REIT Stake as Investors Track Rental Income Trends - The Motley Fool
Truist raises Sabra Healthcare REIT price target to $22 on fundamentals By Investing.com - Investing.com South Africa
Truist raises Sabra Healthcare REIT price target to $22 on fundamentals - Investing.com India
Sabra Healthcare REIT, Inc. $SBRA Position Boosted by Bank of Montreal Can - MarketBeat
Engineers Gate Reduces Holdings in Sabra Health Care REIT Amid Investor Focus on Rental Revenue Patterns - Bitget
Schroder Investment Management Group Grows Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Duff & Phelps Investment Management Co. Cuts Holdings in Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. $SBRA Shares Purchased by Barclays PLC - MarketBeat
Sabra Health Care REIT, Inc. to Participate in Deutsche Bank’s 2026 Healthcare REIT Summit - Business Wire
Cantor Fitzgerald Initiates Coverage of Sabra Health Care REIT (SBRA) with Neutral Recommendation - MSN
Sabra Healthcare REIT announces executive leadership transition - MSN
Victory Capital Management Inc. Buys 124,207 Shares of Sabra Healthcare REIT, Inc. $SBRA - MarketBeat
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SBRA SEC FilingsSabra Health Care Reit Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sabra Health Care REIT Hits New 52-Week High at $20.88 - Markets Mojo
Sabra Health Care REIT, Inc. Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo
Wells Fargo Maintains Sabra Health Care REIT (SBRA) Overweight Recommendation - MSN
Sabra Health Care REIT Hits New 52-Week High at $21.07 - Markets Mojo
Sabra Health Care (SBRA) director granted 781 dividend-equivalent units - Stock Titan
[Form 4] Sabra Health Care REIT, Inc. Insider Trading Activity - Stock Titan
Director Lynne Katzmann receives 781 SBRA stock units under 2009 plan - Stock Titan
Sabra Health Care REIT (SBRA) director credited 781 dividend-equivalent stock units - Stock Titan
Director at Sabra Health Care REIT (SBRA) receives 781 stock units award - Stock Titan
Dividend-based 781-unit stock grant to Sabra (SBRA) board director - Stock Titan
Sabra Health Care REIT (SBRA) EVP granted dividend-equivalent stock units - Stock Titan
Sabra Health Care (SBRA) EVP credited 478 dividend stock units - Stock Titan
Finanzdaten der Sabra Healthcare Reit Inc-Aktie (SBRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sabra Healthcare Reit Inc-Aktie (SBRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FOSTER MICHAEL J | Director |
May 20 '25 |
Sale |
18.22 |
11,000 |
200,376 |
64,725 |
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):